𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical observation on the association of gallstones and colorectal cancer

✍ Scribed by Tomio Narisawa; Yoshihiko Yamazaki; Hisashi Kusaka; Masahiro Takahashi; Hitoshi Kotanagi; Kenji Koyama


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
480 KB
Volume
67
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


A possible association between gallstones, colorectal cancer, and gastric cancer was investigated. The age distribution and mean age of the two cancer groups were identical. The incidence of gallstones in 378 colorectal cancer cases and 869 gastric cancer cases was 7.1% and 5.5%, respectively. Of colorectal cancer cases, 33 cases with multiple carcinomas had a significantly higher gallstone incidence than cases with a solitary carcinoma-24.2% and 5.5%, respectively. The mean age was 5 years older in gallstone cases than in those without gallstones in both cancer groups, and it was 4 years older in multiple-carcinoma cases than in solitarycarcinoma cases in the colorectal cancer group. These results suggest that the higher levels of same causative factors (i.e., dietary fat) are associated with a longer duration of gallstone formation and colorectal cancer development as demonstrated by multiple colorectal-carcinoma cases. Cancer 67:1696-1700,1991.

OLORECTAL CANCER A N D GALLSTONES are two C common diseases in Western countries. A positive association between colorectal cancer and gallstones was demonstrated in postmortem and clinical although one report found no obvious association between these two diseases.' Dietary factors, high-fat and low-fiber intake, have been implicated in colorectal cancer. The luminal contents of the large bowel, including high concentrations of bile acid (particularly secondary bile acids stemming from the high-fat diet), account for the effect in large bowel carcinogenesis.' Such diets also have been suggested as one of the etiologic factors in gallstone formation.' However, the presence of gallstones and the removal of the gallbladder cause an increased level of secondary bile acids in the bile and feces. Decreased pool size and increased enterohepatic recycling of bile acids lead to increased degradation of primary bile acids to secondary bile acids by intestinal microflora.'*-'' It was re-


πŸ“œ SIMILAR VOLUMES


Investigation on the presence of polyoma
✍ Valentina Militello; Marta Trevisan; Laura Squarzon; Maria Angela Biasolo; Massi πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 63 KB

Studies in literature suggest that some human viruses, including JC polyomavirus (JCV), 1-3 human cytomegalovirus (HCMV), 4 human papillomaviruses (HPVs), and Epstein-Barr virus (EBV), 9,10 have a pathogenic role in starting or promoting colorectal cancer. However, a revision of the literature indi

Association of hereditary hemorrhagic te
✍ Neta Goldschmidt; Shulamit Metzger; Isaiah D. Wexler; Orit Goldshmidt; Tiberiu H πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 182 KB πŸ‘ 1 views

Endoglin (CD105) is a proliferation-associated protein that is strongly expressed in endothelial tissue and has a role in tumor angiogenesis. Mutations in endoglin are also linked to Hereditary Hemorrhagic Telangiectasia type 1 (HHT1), an autosomal dominant disease associated with aberrant angiogene

Cancer clinical trial recruitment : The
✍ Martin Tattersall πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 46 KB πŸ‘ 1 views

Clinical Research Associates have assumed an expanding role in the conduct and design of clinical trial protocols. The perspectives of these health professionals are presented in the referenced articles, and implications for clinical trials are discussed. See also pages 1577–83 and 1584–91.

Clinical significance of serum p53 antib
✍ Takeda, Akihiko; Nakajima, Kazuaki; Shimada, Hideaki; Imaseki, Hideo; Takayama, πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 2 views

Background and Objectives: Alteration of the p53 gene product occurs frequently during progression of colorectal cancer. Recently, mutated p53 protein was found to induce the production of anti-p53 antibodies in the serum of patients. The purpose of this study was to evaluate the relationship betwee